||MainLY patients in the epidemic-stricken
area of EHF between the age of 16-60.
||1. IM in the deltoid of the upper arm.
2. Inject 1 ml in first day, eighth day and twenty-ninth day of the
3. Inject another 1 ml dose 6-12 months after the first injection
for patients in the most dangerous epidemic-stricken area.
|| Patients with severe epidemic diseases, fever,
chronic cardiovascular diseases, and severe allergic symptoms should
not allowed to use this drug; pregnant women should use it carefully.
||Generally no reactions or slight reactions occur
after the injection of this drug; for patients with slow absorption,
sometimes local small hard knots will occur.
to Pay Attention to]:
||1. Fully shake up before injection for the vaccine
2. If color changes (changed to yellow or purple), and foreign matters
and cracks occur on the ampoules occur, the drug should not be allowed
|[Storage and Transportation]:
||Stored and transported at 2-8